GL1X · GenesisL1 explorer

MolNFT v1 · #86469 · protein

H1N1 2009 pandemic influenza virus: resistance of the I223R neuraminidase mutant explained by kinetic and structural analysis

4B7M: “H1N1 2009 pandemic influenza virus: resistance of the I223R neuraminidase mutant explained by kinetic and…”. X-ray diffraction, 3 ligands (NAG, CA, PO4), 4 pockets (best druggability 0.66). MolNFT v1 #86469 on GenesisL1: 3D…

PDB
4B7M
Type
protein
Length
772 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Neuraminidase
UniProt
F8UU09
Ligands
NAG, CA, PO4
Pockets
4 · best druggability 0.66

Structure

x-ray diffraction · 1 distinct chain · 3% helix, 46% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BNeuraminidaseprotein3863% helix, 46% strandF8UU09

Ligands and binding sites

  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 9 copies · chains A, B
  • CA · Calcium ion · metal · 2 copies · chains A, B
  • PO4 · Phosphate ion · ion · 4 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13830.660.8051PO4
23710.660.8049PO4
32000.610.8225empty
4620.320.7618empty

Interfaces

1 interface between chains.

  • A–B · 1630 Ų buried · 24 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 15 disulfide, 6 glycan (disulfide, N-glycosylation).

Compared structures

  • 4B7M · H1N1 2009 Pandemic Influenza Virus: Resistance of the I223R Neuraminidase Mutant… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.